Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Jerry Tracy

Pain Medicine Melbourne, FL Medical Doctor

NPI 1477506251 CMS profile 293998

308 S Harbor City Blvd Ste A, Melbourne, FL 32901

Open in the dashboard

General payments

$3,242

118 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Jerry Tracy of Melbourne, FL is reported in the CMS Open Payments database as having received $3,242 across 118 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 55th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $17 1
2023 General $284 5
2022 General $320 14
2020 General $1,467 15
2019 General $1,153 83

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jerry Tracy
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Jerry Tracy were reported at $0. Among 757 Pain Medicine profiles paid that year, the median was $470 and the middle half received between $146 and $1,462.

Show as a table
Year Jerry Tracy Pain Medicine median Middle half National median
2019 $1,153 $506 $144–$1,566 $163
2020 $1,467 $315 $96–$934 $114
2021 $0 $452 $134–$1,237 $132
2022 $320 $475 $124–$1,407 $149
2023 $284 $480 $136–$1,384 $160
2024 $17 $521 $164–$1,511 $164
2025 $0 $470 $146–$1,462 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Abbott Laboratories $861 43 payments
  2. Vertos Medical, Inc. $799 4 payments
  3. Medtronic, Inc. $366 9 payments
  4. Boston Scientific Corporation $318 13 payments
  5. Medtronic USA, Inc. $153 7 payments
  6. Nevro Corp. $94 3 payments
  7. Scilex Pharmaceuticals Inc. $86 5 payments
  8. Collegium Pharmaceutical, Inc. $75 5 payments
  9. Amgen Inc. $73 4 payments
  10. Pfizer Inc. $60 4 payments
  11. Other $357 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $2,608 116 payments
  2. Travel and Lodging $634 2 payments
Products named General payments · program years 2019–2024
  1. mild Device Kit $755 3 payments
  2. Proclaim Family of SCS IPGs $476 13 payments
  3. Neuromodulation Dspsbls and Accs $352 27 payments
  4. VENASEAL $258 4 payments
  5. GENERAL - PAIN MANAGEMENT $153 3 payments
  6. SPECTRA WAVEWRITER $98 6 payments
  7. Senza Spinal Cord Stimulation System $94 3 payments
  8. INTELLIS ADAPTIVESTIM $78 4 payments
  9. XTAMPZA $75 5 payments
  10. AIMOVIG $73 4 payments
  11. Other $982 58 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

23

Median for Pain Management: 951

Drug cost

$267

Median for Pain Management: $26,034

Branded share of claims

0%

Median for Pain Management: 29.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 23 $267

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,732 Part D prescribers listed as Pain Management; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 15 billing codes

Paid by Medicare

$13,623

Medicare's payments for the services billed

Medicare patients

74

Average age 74

Services billed

178

47 women, 27 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 43%
Diabetes 41%
COPD 39%
Ischemic heart disease 30%
Chronic kidney disease 28%
Atrial fibrillation 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

118 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record